Filters close
Released: 16-Sep-2019 10:00 AM EDT
Penn’s Angela DeMichele, MD, MSCE, Part of Team Awarded Stand Up 2 Cancer Grant
Perelman School of Medicine at the University of Pennsylvania

A new $3 million grant to support a clinical trial evaluating a combination therapy to prevent triple-negative breast cancer from recurring, which will be led in the clinic by Angela DeMichele, MD, MSCE, the Alan and Jill Miller Professor in Breast Cancer Excellence in the Abramson Cancer Center (ACC) at the University of Pennsylvania and co-director of the ACC’s 2-PREVENT Translational Center of Excellence. The grant was awarded by Stand Up 2 Cancer (SU2C) in partnership with Genentech, and will be administered by the organization’s scientific partner, the American Association for Cancer Research (AACR).

6-Sep-2019 12:05 PM EDT
Hepatitis C-Infected Kidneys Function Similar to Uninfected Organs One Year After Transplant
Perelman School of Medicine at the University of Pennsylvania

Kidneys from donors who were infected with the Hepatitis C virus (HCV) function just as well as uninfected kidneys throughout the first year following transplantation, according to a new Penn Medicine study.

Released: 12-Sep-2019 2:05 PM EDT
Penn Announces Completion of Exclusive R&D Alliance With Novartis and Development of New Focused Relationship
Perelman School of Medicine at the University of Pennsylvania

The University of Pennsylvania and Novartis have concluded their seven-year research and development alliance, which resulted in the world’s first approved gene therapy for cancer. They will continue to work together on a more narrow CAR T cell therapy clinical trials portfolio.

11-Sep-2019 9:30 AM EDT
Two Studies Show Promise, Safety of Proton Therapy in the Brain in Children with Cancer
Perelman School of Medicine at the University of Pennsylvania

From improving outcomes in children with brain cancer to lowering the risk of damage to the brainstem in children with central nervous system tumors, a pair of new studies published today add to the growing body of research showing the potential benefits of proton therapy.

6-Sep-2019 11:30 AM EDT
CAR T-Cell Therapy May Be Harnessed to Treat Heart Disease
Perelman School of Medicine at the University of Pennsylvania

A new Penn Medicine study, published in Nature, revealed, in mice, that CART T-cell therapy may now be harnessed to treat heart disease. Researchers used genetically modified T cells to target and remove activated fibroblasts that contribute to the development of cardiac fibrosis.

5-Sep-2019 11:20 AM EDT
Using a Wearable Device to Exercise More? Add Competition to Improve Results
Perelman School of Medicine at the University of Pennsylvania

A clinical trial using a behaviorally designed gamification program found competition worked better than support or collaboration to increase daily step counts

Released: 6-Sep-2019 5:05 PM EDT
Minority Students Still Underrepresented in Medical Schools
Perelman School of Medicine at the University of Pennsylvania

While numbers of black and Hispanic physicians have increased, Penn study shows the physician workforce does not represent the shifting demographics of the U.S. population.

Released: 5-Sep-2019 11:00 AM EDT
Penn Researcher Virginia M.Y. Lee, PhD, Receives $3 Million Breakthrough Prize
Perelman School of Medicine at the University of Pennsylvania

Virginia M.Y. Lee, PhD, the John H. Ware 3rd Professor in Alzheimer’s Research in the Department of Pathology and Laboratory Medicine and director of the Center for Neurodegenerative Disease Research at the University of Pennsylvania, will receive the Breakthrough Prize in Life Sciences.

Released: 4-Sep-2019 4:35 PM EDT
Patients in the U.S. and Canada are Seven Times as Likely as those in Sweden to Receive Opioids After Surgery
Perelman School of Medicine at the University of Pennsylvania

Patients in the United States and Canada are seven times as likely as those in Sweden to receive a prescription for opioid medications after surgery, according to a new multi-institutional study led by researchers from Penn Medicine.

28-Aug-2019 4:30 PM EDT
Providing More Testing Choices Does Not Increase Colorectal Cancer Screening Rates
Perelman School of Medicine at the University of Pennsylvania

A study showed that choice of screening options alone does not impact screening rates, but how the choice is offered can alter patient decision-making.

27-Aug-2019 9:15 AM EDT
Blocking Specific Protein Could Provide a New Treatment for Deadly Form of Prostate Cancer
Perelman School of Medicine at the University of Pennsylvania

Blocking a kinase known as CDK7 sets off a chain reaction that results in the death of prostate cancer cells that have spread and are resistant to standard therapies

Released: 28-Aug-2019 4:30 PM EDT
Giving Trauma Patients a Hormone that Helps Stabilize Blood Pressure Cuts Blood Transfusions by Half
Perelman School of Medicine at the University of Pennsylvania

Giving trauma patients with severe blood loss the hormone arginine vasopressin (AVP) cut the volume of blood products required to stabilize them by half, according to results of a new, first-of-its-kind clinical trial from Penn Medicine. The authors say the study is particularly important for the treatment of patients with gun-related injuries. Each year, there are over 100,00 firearm-related injuries with over 36,000 deaths.

Released: 27-Aug-2019 9:30 AM EDT
Penn Psychiatry and Radiology Researchers Join Forces to Create New Center of Excellence for Opioid Use Disorders
Perelman School of Medicine at the University of Pennsylvania

The new Penn PET Addiction Center of Excellence—funded by a five-year, $8.9 million grant from the National Institute on Drug Abuse—will be the first of its kind dedicated to the use of PET imaging to investigate the neurobiology of people suffering from opioid use disorders.

Released: 26-Aug-2019 2:45 PM EDT
Text Instructions, Reminders Boost Rates of Colonoscopies
Perelman School of Medicine at the University of Pennsylvania

Having simple text conversations with patients one week before they are scheduled for a colonoscopy dramatically decreased the “no-show” rates.

22-Aug-2019 1:05 PM EDT
Many Kidneys Discarded in the United States Would Be Transplanted in France
Perelman School of Medicine at the University of Pennsylvania

French organ transplant centers are far more likely to accept “lower-rated” kidneys, like those from older organ donors, than centers in the United States, according to a study published today in JAMA Internal Medicine.

Released: 21-Aug-2019 8:25 AM EDT
Nicotine-Free E-Cigarettes Can Damage Blood Vessels
Perelman School of Medicine at the University of Pennsylvania

MRI scans on 31 individuals showed that vaping temporarily impacts blood vessel function in healthy people.

19-Aug-2019 8:50 AM EDT
Helping Skin Cells Differentiate Could Be Key to Treating Common Skin Cancer
Perelman School of Medicine at the University of Pennsylvania

A new study from Penn researchers has identified a key regulator of a process that controls skin regeneration, which can control whether cells turn into a common skin cancer.

12-Aug-2019 9:20 AM EDT
Treatment Doctor Tested On Himself Can Put Others into Remission
Perelman School of Medicine at the University of Pennsylvania

Castleman Disease patients who do not respond to the only drug currently approved by the FDA may have another option that targets a specific pathway called PI3K/Akt/mTOR

Released: 8-Aug-2019 2:05 PM EDT
#WomenofPenn: Time for the Circadian Field
Perelman School of Medicine at the University of Pennsylvania

This post is part of a year-long online campaign highlighting #WomenofPenn. The campaign, developed by FOCUS on Women’s Health and Leadership and Penn Medicine Communications promotes the work being done by women at Penn Medicine and aims to inspire early-career women in academic medicine through the examples of successful women role models.

7-Aug-2019 2:00 PM EDT
Balance of “Stop” and “Go” Signaling Could Be Key to Cancer Immunotherapy Response
Perelman School of Medicine at the University of Pennsylvania

A crucial signaling pathway that can tell the immune system to fight off cancer can also be co-opted by cancer cells to put the brakes on the immune system.

Released: 8-Aug-2019 10:35 AM EDT
The Brain’s Amyloid Buildup is Not a Powerful Measure of Alzheimer’s Disease Severity
Perelman School of Medicine at the University of Pennsylvania

Researchers find fluorodeoxyglucose (FDG) PET is a better indicator of cognitive performance when compared to PET scans that detect amyloid protein.

Released: 6-Aug-2019 4:05 PM EDT
The Legacy of PARS
Perelman School of Medicine at the University of Pennsylvania

PARS is an all-female workshop led by clinicians, scientists, and medical students for high school students interested in exploring the world of health care and medicine, particularly reproductive science.

Released: 1-Aug-2019 1:05 PM EDT
Peering into the Soul of the Immune System to Better Fight Disease
Perelman School of Medicine at the University of Pennsylvania

A rare, short-lived population of immune cells in the bloodstream may serve as ‘periscopes’ to monitor immune status via lymph nodes deep inside the body.

23-Jul-2019 1:05 PM EDT
Penn Biochemists Streamline Construction Method for Human Artificial Chromosomes
Perelman School of Medicine at the University of Pennsylvania

Researchers describe a new way to form an essential part of an artificial chromosome, called the centromere, by bypassing the biological requirements needed to form a natural one.

Released: 24-Jul-2019 11:05 AM EDT
Deputy Director of Penn’s Abramson Cancer Center Receives $3 Million Grant from The Gray Foundation
Perelman School of Medicine at the University of Pennsylvania

Katherine L. Nathanson, MD, deputy director of the Abramson Cancer Center at the University of Pennsylvania and the Pearl Basser Professor for BRCA-Related Research in Penn’s Perelman School of Medicine, has been awarded a $3 million research grant from the Gray Foundation.

Released: 19-Jul-2019 11:05 AM EDT
Taking out the Protein Garbage Becomes More Difficult as Neurons Age
Perelman School of Medicine at the University of Pennsylvania

As cells age, their ability to shed harmful refuse declines. New research findings suggest that the deterioration of autophagy in aged neurons—cells that never replicate and are as old as the bodies they inhabit—could be a risk factor for a suite of neurodegenerative diseases such as ALS (amyotrophic lateral sclerosis), Alzheimer’s, and Parkinson’s.

18-Jul-2019 3:30 PM EDT
Music Can Be a Viable Alternative to Medications in Reducing Anxiety Before Anesthesia Procedures
Perelman School of Medicine at the University of Pennsylvania

Music is a viable alternative to sedative medications in reducing patient anxiety prior to an anesthesia procedure, according to a Penn Medicine study published today in the journal Regional Anesthesia & Pain Medicine.

Released: 16-Jul-2019 11:40 AM EDT
Penn Medicine and Grand View Health Announce Orthopaedic Care Partnership
Perelman School of Medicine at the University of Pennsylvania

The alliance between Penn Medicine and Grand View Health will expand access to orthopaedic care for patients in Pennsylvania's Bucks and Montgomery counties and their surrounding areas.

Released: 15-Jul-2019 8:05 AM EDT
Early and Ongoing Experiences of Weight Stigma Linked to Self-Directed Weight Shaming
Perelman School of Medicine at the University of Pennsylvania

Researchers at Penn Medicine surveyed more than 18,000 adults enrolled in a commercial weight management program, and found that participants who internalized weight bias the most tended to be younger, female, have a higher body mass index, and have an earlier onset of their weight struggle.

9-Jul-2019 11:00 AM EDT
Adding Immunotherapy After Initial Treatment Can Benefit Metastatic Lung Cancer Patients
Perelman School of Medicine at the University of Pennsylvania

Treating metastatic non-small cell lung cancer (NSCLC) patients with the immunotherapy drug pembrolizumab after they’ve completed locally ablative therapy almost tripled the median progression-free survival compared to the historical average.

Released: 11-Jul-2019 10:05 AM EDT
Synthetic Biologist Named Penn Presidential Professor
Perelman School of Medicine at the University of Pennsylvania

César de la Fuente, PhD, has joined the Perelman School of Medicine at the University of Pennsylvania as a Presidential Assistant Professor in the departments of Psychiatry and Microbiology, in addition to the department of Bioengineering at Penn.

28-Jun-2019 1:05 PM EDT
Cardiac Genetic Mutation May Not Always Predict Heart Disease
Perelman School of Medicine at the University of Pennsylvania

One in 10 people with dilated cardiomyopathy were born with a mutation in the TTN gene, but – until now – it has been unclear whether everyone with these mutations will inevitably develop the condition. Researchers found that 95 percent of patients who had the genetic mutations did not have heart disease.

27-Jun-2019 11:00 AM EDT
Researchers Identify New Way to Make Cancer Self-Destruct
Perelman School of Medicine at the University of Pennsylvania

Researchers have identified a new pathway that can cause cancer to grow too quickly and die from the stress.

Released: 1-Jul-2019 9:00 AM EDT
Shorter Courses of Proton Therapy Can Be Just as Effective as Full Courses in Treating Prostate Cancer
Perelman School of Medicine at the University of Pennsylvania

Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments and is safe for patients

Released: 1-Jul-2019 9:00 AM EDT
Penn Medicine Hospitals to be Named 2019 Leaders in LGBTQ Healthcare Equality by the Human Rights Campaign
Perelman School of Medicine at the University of Pennsylvania

All six of Penn Medicine’s hospitals will be recognized as 2019 leaders in LGBTQ healthcare equality by the Human Rights Campaign (HRC) Foundation.

25-Jun-2019 12:45 PM EDT
One Simple Change Cut Unnecessary Imaging for Cancer Patients in Half
Perelman School of Medicine at the University of Pennsylvania

Introducing a default physician order — a “nudge” — into electronic health records (EHRs) cut the use of unnecessary daily imaging in half during palliative radiation therapy sessions for patients with advanced cancer

Released: 26-Jun-2019 9:30 AM EDT
In Philadelphia’s Mental Health Clinics, Use of Evidence-based Therapies for Youth Psychiatric Treatment is Slow to Catch On, Despite Investments
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine researchers found that over a five-year period in Philadelphia, use of evidence-based therapies—practices backed by scientific data showing that symptoms improve in response to treatment, such as cognitive behavioral therapy (CBT)—increased only modestly, despite the city and researchers’ substantial efforts to showcase the value of these approaches and to provide training to community clinicians.

Released: 26-Jun-2019 12:00 AM EDT
From Simple Tools to High-Level Buy-In, How Doctors Can Help Cancer Patients Quit Tobacco
Perelman School of Medicine at the University of Pennsylvania

A simple set of decision-support tools combined with institutional buy-in can help increase the number of cancer patients who engage in treatment to help them quit tobacco, data from researchers in the Abramson Cancer Center at the University of Pennsylvania show.

24-Jun-2019 12:05 PM EDT
Shorter Rotations in Intensive Care Units Mitigate Burnout Among Physicians
Perelman School of Medicine at the University of Pennsylvania

Shortening the length of rotations in a medical intensive care unit (MICU) from the traditional 14-consecutive day schedule to only seven days helps mitigate burnout among critical care physicians, according to a new Penn Medicine pilot study published in the American Journal of Respiratory and Critical Care Medicine.

   
Released: 20-Jun-2019 4:05 PM EDT
Many Elderly Patients with Metastatic Renal Cell Carcinoma Benefit from Targeted Therapies
Perelman School of Medicine at the University of Pennsylvania

Many elderly patients with metastatic renal cell carcinoma (RCC)—who are often underrepresented in clinical trials to treat the kidney cancer—are seeing overall survival benefits from treatment with targeted therapies, according to a new study from Penn Medicine researchers published this month in JAMA Network Open. Analyzing 13 years of data on Medicare patients, the study found that the patients who received targeted therapies were more medically complex than those who received the older, more toxic treatments that were available earlier in the study period, indicating that newer treatments are offering hope to more people.

17-Jun-2019 10:05 AM EDT
Collegiate Affirmative Action Bans Linked to Increase in Smoking among Minority High School Students
Perelman School of Medicine at the University of Pennsylvania

College affirmative action bans may adversely affect the health of underrepresented minority high school students, according to the results of a new study from researchers at Penn Medicine. Between 1996 and 2013, nine U.S. states banned consideration of race and ethnicity in college admissions. A new study in PLOS Medicine shows that the action bans had unanticipated effects, specifically resulting in increased rates of smoking among minority high school students

Released: 18-Jun-2019 1:05 PM EDT
Size Matters: New Data Reveals Cell Size Sparks Genome Awakening in Embryos
Perelman School of Medicine at the University of Pennsylvania

Transitions are a hallmark of life, and so there is a transition during early development when an embryo undergoes biochemical changes, switching from being controlled by maternal molecules to being governed by its own genome. For the first time, researchers have found in an embryo that activation of its genome does not happen all at once, instead it follows a specific pattern controlled primarily by the various sizes of its cells.

13-Jun-2019 12:05 PM EDT
Facebook Posts Better at Predicting Diabetes, Mental Health Than Demographic Info
Perelman School of Medicine at the University of Pennsylvania

Analyzing language shows that identifying certain groups of words significantly improves upon predicting some medical conditions in patients

14-Jun-2019 8:05 AM EDT
How to Reinvigorate Exhausted Immune Cells and Stop Cancer Along the Way
Perelman School of Medicine at the University of Pennsylvania

In cancer and chronic infections immune balance can be disrupted, resulting in immune system dysfunction or “exhaustion.” An important protein called TOX, which varies in amount in different immune cell types, controls the identity of the cells that become exhausted. With this knowledge, investigators now have a way to accurately identify immune cells that are exhausted in a tumor or site of an infection and improve the effectiveness of patients’ immune response to treatment.

Released: 13-Jun-2019 10:05 AM EDT
Common Conditions Keep Many Patients Out of Knee Cartilage Research Studies
Perelman School of Medicine at the University of Pennsylvania

Issues like age or existing arthritis may preclude patients from participating in clinical studies for new therapies that could benefit them

7-Jun-2019 2:05 PM EDT
People with Untreated “White Coat Hypertension” Twice as Likely to Die from Heart Disease
Perelman School of Medicine at the University of Pennsylvania

A new Penn Medicine study, published today in the Annals of Internal Medicine, revealed that patients with untreated white coat hypertension not only have a heightened risk of heart disease, but they are twice as likely to die from heart disease than people with normal blood pressure.

Released: 5-Jun-2019 3:30 PM EDT
Replicating Fetal Bone Growth Process Could Help Heal Large Bone Defects
Perelman School of Medicine at the University of Pennsylvania

To treat large gaps in long bones, like the femur, that often eventually result in amputation, researchers developed a process that partially recreates the bone growth process that occurs before birth.

Released: 3-Jun-2019 10:00 AM EDT
Penn Receives $12 Million Grant to Study Connection Between Radiation and Immunotherapies
Perelman School of Medicine at the University of Pennsylvania

From understanding the genetics of cancer cells to improving cellular therapies and incorporating new methods of radiation therapy, a $12 million grant will help researchers at the Abramson Cancer Center at the University of Pennsylvania pursue the next generation of cancer treatments.

Released: 31-May-2019 3:05 AM EDT
Childhood Adversity Linked to Earlier Puberty, Premature Brain Development, and Greater Mental Illness
Perelman School of Medicine at the University of Pennsylvania

Growing up in poverty and experiencing traumatic events like a bad accident or sexual assault were linked to accelerated puberty and brain maturation, abnormal brain development, and greater mental health disorders, such as depression, anxiety, and psychosis, according to a new Penn Medicine study published this week in JAMA Psychiatry.



close
0.39198